Novavax reported $760K in Ordinary Share Capital for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ordinary Share Capital Change
Adamas Pharmaceuticals ADMS:US 50K 0
Adma Biologics ADMA:US $ 0.01M 0M
Astrazeneca AZN:US $ 387M 59M
AstraZeneca AZN:LN 387M 59M
Dynavax Technologies DVAX:US $ 0.12M 0.01M
Genocea Biosciences GNCA:US $ 0.06M 0M
Geron GERN:US $ 0.32M 0M
GlaxoSmithKline GSK:LN 1347M 0M
Kindred Biosciences KIN:US $ 0M 0M
Mannkind MNKD:US $ 2.5M 0.01M
Minerva Neurosciences NERV:US $ 0M 0M
Moderna Inc MRNA:US 40.5K 40.5K
Novartis NVS:US $ 901M 12M
Novavax NVAX:US $ 0.76M 0.01M
Pain Therapeutics PTIE:US $ 460.7M 0.65M
Peregrine Pharmaceuticals PPHM:US $ 0.06M 0M
Sarepta Therapeutics SRPT:US $ 0.01M 0M